Dermal Lipofuscinosis Associated With Amiodarone Therapy
- 1 May 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 120 (5) , 646-649
- https://doi.org/10.1001/archderm.1984.01650410088022
Abstract
• Amiodarone hydrochloride is a noncompetitive adrenergic blocker used in the treatment of tachyarrhythmias. Its use in Europe and South America has been associated with cutaneous pigmentation thought to be caused by lipofuscin deposition in the dermis. We describe a similar case occurring in North America. A skin biopsy specimen from the patient was examined by light microscopy, fluoresence microscopy, and electron microscopy. From these examinations, a diagnosis of dermal lipofuscinosis was made. (Arch Dermatol 1984;120:646-649)Keywords
This publication has 1 reference indexed in Scilit:
- New antiarrhythmic agents: Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamilThe American Journal of Cardiology, 1978